EGF (1-51), Human

Epidermal Growth Factor (1-51 a.a.)Human Recombinant
Cat. No.
BT2934
Source

Saccharomyces cerevisiae

Synonyms

Urogastrone, URG, EGF.

Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

Purity

Greater than 98.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Epidermal Growth Factor (1-51 a.a.) Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing 51 amino acids and having a molecular mass of 6.0kDa. The EGF is purified by proprietary chromatographic techniques. 

Product Specs

Introduction

Epidermal growth factor (EGF) plays a crucial role in cell differentiation, acting as a potent mitogen for various cultured cells. It stimulates the growth of epidermal, epithelial, and fibroblast cells. EGF is synthesized as a membrane-bound precursor and then proteolytically cleaved into a 53-amino acid peptide hormone that promotes cell division.

Description

This product is a recombinant human Epidermal Growth Factor (EGF) comprising amino acids 1-51. It is produced in yeast and purified as a single, glycosylated polypeptide chain with a molecular weight of 6.0 kDa. The purification process involves proprietary chromatographic techniques.

Physical Appearance

Sterile, lyophilized powder with a white color.

Formulation

The product is lyophilized from a 0.2 µm filtered solution in phosphate-buffered saline (PBS) at pH 7.4.

Solubility

To reconstitute, dissolve the lyophilized EGF in sterile 18 MΩ-cm H2O to a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions.

Stability

The lyophilized EGF is stable at room temperature for up to 3 weeks; however, it is recommended to store it desiccated below -18°C. After reconstitution, store the solution at 4°C for up to 7 days. For long-term storage, keep it at -18°C. Avoid repeated freeze-thaw cycles.

Purity

The purity of this product is greater than 98%, as determined by reversed-phase high-performance liquid chromatography (RP-HPLC) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).

Biological Activity

The ED50, determined by a cell proliferation assay using murine Balb/c 3T3 cells, is less than 0.1 ng/ml. This corresponds to a specific activity greater than 1.0 × 107 IU/mg.

Synonyms

Urogastrone, URG, EGF.

Source

Saccharomyces cerevisiae

Amino Acid Sequence

NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW E.

Product Science Overview

Introduction

Epidermal Growth Factor (EGF) is a crucial cytokine that plays a significant role in regulating various cellular processes. The recombinant form of EGF, specifically the 1-51 amino acid sequence, has been extensively studied for its potential therapeutic applications. This article delves into the background, molecular dynamics, and therapeutic promise of Epidermal Growth Factor (1-51 a.a.)(Human Recombinant).

Molecular Structure and Production

Epidermal Growth Factor (1-51 a.a.) Human Recombinant is a single, glycosylated polypeptide chain containing 51 amino acids. It has a molecular mass of approximately 6.0 kDa . The recombinant EGF is produced in yeast (Saccharomyces cerevisiae) and is purified using proprietary chromatographic techniques .

Biological Activity

EGF exerts its effects by binding to the EGF receptor (EGFR), a 170 kDa protein kinase. This binding initiates various cellular pathways, including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC, and STAT modules . These pathways are crucial for cell proliferation, differentiation, and survival. The ED50 of EGF (1-51 a.a.) is determined by a cell proliferation assay using murine Balb/c 3T3 cells and is less than 0.1 ng/ml, corresponding to a specific activity of greater than 1.0 × 10^7 IU/mg .

Therapeutic Applications

Recombinant human EGF has shown promise in various therapeutic applications. It is used to treat diabetic foot ulcers, where it can be administered by injection into the wound site or applied topically . EGF stimulates the growth of several epidermal and epithelial tissues in vivo and in vitro, making it a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin .

Stability and Storage

Lyophilized EGF is stable at room temperature for up to three weeks but should be stored desiccated below -18°C for long-term storage. Upon reconstitution, it should be stored at 4°C for short-term use (2-7 days) and below -18°C for future use. It is essential to prevent freeze-thaw cycles to maintain its stability .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.